药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
19-Nor-4-androstenedione
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Pazufloxacin.
19-Nor-4-androstenedione
Talinolol
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Talinolol.
19-Nor-4-androstenedione
Ebastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Ebastine.
19-Nor-4-androstenedione
Rupatadine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Rupatadine.
19-Nor-4-androstenedione
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Bilastine.
19-Nor-4-androstenedione
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Bilastine.
19-Nor-4-androstenedione
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Bilastine.
19-Nor-4-androstenedione
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Bilastine.
19-Nor-4-androstenedione
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Bilastine.
19-Nor-4-androstenedione
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Bilastine.
19-Nor-4-androstenedione
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Bilastine.
19-Nor-4-androstenedione
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Bilastine.
19-Nor-4-androstenedione
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Bilastine.
19-Nor-4-androstenedione
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Bilastine.
19-Nor-4-androstenedione
Efonidipine
The risk or severity of QTc prolongation can be increased when Efonidipine is combined with Bilastine.
19-Nor-4-androstenedione
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Bilastine.
19-Nor-4-androstenedione
Dosulepin
The risk or severity of QTc prolongation can be increased when Dosulepin is combined with Bilastine.
19-Nor-4-androstenedione
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Bilastine.
19-Nor-4-androstenedione
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Bilastine.
19-Nor-4-androstenedione
Vilanterol
The risk or severity of QTc prolongation can be increased when Vilanterol is combined with Bilastine.